Patents by Inventor Johannes Kobberling
Johannes Kobberling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10118930Abstract: The present application relates to novel substituted piperidinylpyrazolopyrimidinones, to processes for their preparation, the compounds for use alone or in combinations in a method for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of acute and recurrent bleeding in patients with or without underlying hereditary or acquired hemostatic disorders, wherein the bleeding is associated with a disease or medical intervention selected from the group consisting of heavy menstrual bleeding, postpartum hemorrhage, hemorrhagic shock, hemorrhagic cystitis, gastrointestinal hemorrhage, trauma, surgery, transplantation, stroke, liver diseases, hereditary angioedema, nosebleed, and synovitis and cartilage damage following hemarthrosis.Type: GrantFiled: October 30, 2015Date of Patent: November 6, 2018Assignee: BAYER PHARMA AKTIENGESELLSCHAFTInventors: Manuel Ellermann, Gaelle Valot, Yolanda Cancho Grande, Jorma Haßfeld, Tom Kinzel, Johannes Köbberling, Kristin Beyer, Susanne Röhrig, Michael Sperzel, Jan Stampfuß, Imke Meyer, Maria Köllnberger, Nils Burkhardt, Karl-Heinz Schlemmer, Christian Stegmann, Joachim Schuhmacher, Matthias Werner, Jörg Heiermann, Willem Jan Hengeveld
-
Patent number: 10098883Abstract: The present application relates to novel substituted (aza)pyridopyrazolopyrimidinones and indazolopyrimidinones, to processes for their preparation, the compounds for use alone or in combinations in a method for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of acute and recurrent bleeding in patients with or without underlying hereditary or acquired bleeding disorders, wherein the bleeding is associated with a disease or medical intervention selected from the group consisting of menorrhagia, postpartum hemorrhage, hemorrhagic shock, trauma, surgery, transplantation, stroke, liver diseases, hereditary angioedema, nosebleed, and synovitis and cartilage damage following hemarthrosis.Type: GrantFiled: January 26, 2017Date of Patent: October 16, 2018Assignee: BAYER PHARMA AKTIENGESELLSCHAFTInventors: Jorma Haßfeld, Tom Kinzel, Johannes Köbberling, Yolanda Cancho-Grande, Kristin Beyer, Susanne Röhrig, Maria Köllnberger, Michael Sperzel, Nils Burkhardt, Karl-Heinz Schlemmer, Christian Stegmann, Joachim Schuhmacher, Matthias Werner, Manuel Ellermann
-
Publication number: 20180289007Abstract: The invention relates inter alia to compounds of the general formula (I). Also described are methods for preparing the compounds of the formula (I). The compounds according to the invention are especially suitable for controlling insects, arachnids and nematodes in agriculture, and ectoparasites in veterinary medicine and also as herbicides.Type: ApplicationFiled: August 11, 2016Publication date: October 11, 2018Applicant: Bayer CropScience AktiengesellschaftInventors: Tobias HARSCHNECK, Michael MAUE, Werner HALLENBACH, Alexander ARLT, Robert VELTEN, Reiner FISCHER, Hans-Georg SCHWARZ, Ulrich GÕRGENS, Kerstin ILG, Klaus RAMING, Sebastlan HORSTMANN, Daniela PORTZ, Johannes KÕBBERLING, Andreas TURBERG, Hansjõrg DEITRICH
-
Patent number: 10035818Abstract: The invention relates to novel polyethylene glycol (PEG) based prodrug of Adrenomedullin, to processes for preparation thereof, to the use thereof for treatment and/or prevention of diseases, and to the use thereof for producing medicaments for treatment and/or prevention of diseases, especially of cardiovascular, edematous and/or inflammatory disorders.Type: GrantFiled: March 29, 2017Date of Patent: July 31, 2018Assignees: Bayer Pharma Aktiengesellschaft, Bayer Intellectual Property GmbHInventors: Ingo Flamme, Johannes Köbberling, Hans-Georg Lerchen, Nils Griebenow, Rudolf Schohe-Loop, Sven Wittrock, Maria Köllnberger, Frank Wunder, Gorden Redlich, Andreas Knorr, Julie Marley, Iain Pritchard
-
Patent number: 9936699Abstract: The invention relates inter alia to halogen-substituted compounds of the general formula (I) in which the substituents A1, R1-R3 and Z1-Z3 have the meanings given in the description. Also described are processes for preparing the compounds of the formula (I) and possible intermediates for the preparation of these compounds. The compounds according to the invention are particularly suitable for controlling insects, arachnids and nematodes in agriculture and ectoparasites in veterinary medicine.Type: GrantFiled: August 5, 2015Date of Patent: April 10, 2018Assignee: BAYER CROPSCIENCE AKTIENGESELLSCHAFTInventors: Michael Maue, Tobias Harschneck, Julia Johanna Hahn, Thomas Bretschneider, Anne Decor, Reiner Fischer, Werner Hallenbach, Hans-Georg Schwarz, Robert Velten, Niels Böhnke, Olga Malsam, Ulrich Görgens, Sebastian Horstmann, Klaus Raming, Johannes Köbberling, Walter Hübsch
-
Publication number: 20180044298Abstract: The invention comprises novel pyrazolyl derivatives of the general formula (I) Also described are processes for preparing the compounds of the formula (I). The compounds according to the invention are especially suitable for controlling insects and arachnids in agriculture, and ectoparasites in veterinary medicine.Type: ApplicationFiled: March 9, 2016Publication date: February 15, 2018Applicant: Bayer Animal Health GmbHInventors: HANS-GEORG SCHWARZ, MICHAEL MAUE, WERNER HALLENBACH, ULRICH GÖRGENS, DANIELA PORTZ, KERSTIN ILG, JOHANNES KÖBBERLING, ANDREAS TURBERG
-
Publication number: 20180022780Abstract: The invention relates to novel, biologically active, stabilized Adrenomedullin (ADM) compounds. The invention further relates to the compounds for use in a method for the treatment and/or prevention of diseases, especially of cardiovascular, edematous and/or inflammatory disorders, and to medicaments comprising the compounds for treatment and/or prevention of cardiovascular, edematous and/or inflammatory disorders.Type: ApplicationFiled: September 24, 2015Publication date: January 25, 2018Inventors: Donald BIERER, Ingo FLAMME, Johannes KÖBBERLING, Bernd RIEDL, Annette BECK-SICKINGER, Ria SCHOENAUER, Jan-Patrick FISCHER
-
Publication number: 20170334917Abstract: The present application relates to novel substituted piperidinylpyrazolopyrimidinones, to processes for their preparation, the compounds for use alone or in combinations in a method for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of acute and recurrent bleeding in patients with or without underlying hereditary or acquired hemostatic disorders, wherein the bleeding is associated with a disease or medical intervention selected from the group consisting of heavy menstrual bleeding, postpartum hemorrhage, hemorrhagic shock, hemorrhagic cystitis, gastrointestinal hemorrhage, trauma, surgery, transplantation, stroke, liver diseases, hereditary angioedema, nosebleed, and synovitis and cartilage damage following hemarthrosis.Type: ApplicationFiled: October 30, 2015Publication date: November 23, 2017Applicant: BAYER PHARMA AKTIENGESELLSCHAFTInventors: Manuel ELLERMANN, Gaelle VALOT, Yolanda CANCHO GRANDE, Jorma HAßFELD, Tom KINZEL, Johannes KÖBBERLING, Kristin BEYER, Susanne RÖHRIG, Michael SPERZEL, Jan STAMPFUß, Imke MEYER, Maria KÖLLNBERGER, Nils BURKHARDT, Karl-Heinz SCHLEMMER, Christian STEGMANN, Joachim SCHUHMACHER, Matthias WERNER, Jörg HEIERMANN, Willem Jan HENGEVELD
-
Publication number: 20170239251Abstract: The present application relates to novel substituted (aza)pyridopyrazolopyrimidinones and indazolopyrimidinones, to processes for their preparation, the compounds for use alone or in combinations in a method for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of acute and recurrent bleeding in patients with or without underlying hereditary or acquired bleeding disorders, wherein the bleeding is associated with a disease or medical intervention selected from the group consisting of menorrhagia, postpartum hemorrhage, hemorrhagic shock, trauma, surgery, transplantation, stroke, liver diseases, hereditary angioedema, nosebleed, and synovitis and cartilage damage following hemarthrosis.Type: ApplicationFiled: January 26, 2017Publication date: August 24, 2017Inventors: Jorma HAßFELD, Tom KINZEL, Johannes KÖBBERLING, Yolanda CANCHO-GRANDE, Kristin BEYER, Susanne RÖHRIG, Maria KÖLLNBERGER, Michael SPERZEL, Nils BURKHARDT, Karl-Heinz SCHLEMMER, Christian STEGMANN, Joachim SCHUHMACHER, Matthias WERNER, Manuel ELLERMANN
-
Publication number: 20170223960Abstract: The invention relates inter alia to halogen-substituted compounds of the general formula (I) in which the substituents A1, R1-R3 and Z1-Z3 have the meanings given in the description. Also described are processes for preparing the compounds of the formula (I) and possible intermediates for the preparation of these compounds. The compounds according to the invention are particularly suitable for controlling insects, arachnids and nematodes in agriculture and ectoparasites in veterinary medicine.Type: ApplicationFiled: August 5, 2015Publication date: August 10, 2017Inventors: Michael MAUE, Tobias HARSCHNECK, Julia Johanna HAHN, Thomas BRETSCHNEIDER, Anne DECOR, Reiner FISCHER, Werner HALLENBACH, Hans-Georg SCHWARZ, Robert VELTEN, Niels BÖHNKE, Olga MALSAM, Ulrich GÖRGENS, Sebastian HORSTMANN, Klaus RAMING, Johannes KÖBBERLING, Walter HÜBSCH
-
Publication number: 20170204137Abstract: The invention relates to novel polyethylene glycol (PEG) based prodrug of Adrenomedullin, to processes for preparation thereof, to the use thereof for treatment and/or prevention of diseases, and to the use thereof for producing medicaments for treatment and/or prevention of diseases, especially of cardiovascular, edematous and/or inflammatory disorders.Type: ApplicationFiled: March 29, 2017Publication date: July 20, 2017Inventors: Ingo FLAMME, Johannes KÖBBERLING, Hans-Georg LERCHEN, Nils GRIEBENOW, Rudolf SCHOHE-LOOP, Sven WITTROCK, Maria KÖLLNBERGER, Frank WUNDER, Gorden REDLICH, Andreas KNORR, Julie MARLEY, Iain PRITCHARD
-
Patent number: 9706775Abstract: The invention relates inter alia to halogen-substituted compounds of the general formula (II) in which the radicals A1-A4, T, n, W, Q, R1 and Z1-Z3 have the meanings given in the description. Also described are processes for preparing the compounds of the formula (II). The compounds according to the invention are particularly suitable for controlling insects, arachnids and nematodes in agriculture and ectoparasites in veterinary medicine.Type: GrantFiled: February 27, 2014Date of Patent: July 18, 2017Assignee: BAYER ANIMAL HEALTH GMBHInventors: Michael Maue, Anne Decor, Thomas Bretschneider, Julia Johanna Hahn, Werner Hallenbach, Reiner Fischer, Hans-Georg Schwarz, Ulrich Görgens, Kerstin Ilg, Klaus Raming, Johannes Köbberling, Walter Hübsch, Andreas Turberg
-
Patent number: 9649363Abstract: The invention relates to novel polyethylene glycol (PEG) based prodrug of Adrenomedullin, to processes for preparation thereof, to the use thereof for treatment and/or prevention of diseases, and to the use thereof for producing medicaments for treatment and/or prevention of diseases, especially of cardiovascular, edematous and/or inflammatory disorders.Type: GrantFiled: December 31, 2015Date of Patent: May 16, 2017Assignees: BAYER INTELLECTUAL PROPERTY GMBH, BAYER PHARMA AKTIENGESELLSCHAFTInventors: Ingo Flamme, Johannes Köbberling, Hans-Georg Lerchen, Nils Griebenow, Rudolf Schohe-Loop, Sven Wittrock, Maria Köllnberger, Frank Wunder, Gorden Redlich, Andreas Knorr, Julie Marley, Iain Pritchard
-
Patent number: 9603936Abstract: The invention relates to novel polyethylene glycol (PEG) based prodrug of Adrenomedullin, to processes for preparation thereof, to the use thereof for treatment and/or prevention of diseases, and to the use thereof for producing medicaments for treatment and/or prevention of diseases, especially of cardiovascular, edematous and/or inflammatory disorders.Type: GrantFiled: October 30, 2012Date of Patent: March 28, 2017Assignee: Bayer Intellectual Property GmbHInventors: Ingo Flamme, Johannes Köbberling, Hans-Georg Lerchen, Nils Griebenow, Rudolf Schohe-Loop, Sven Wittrock, Maria Köllnberger, Frank Wunder, Gorden Redlich, Andreas Knorr, Julie Marley, Iain Pritchard
-
Patent number: 9598417Abstract: The present application relates to novel substituted (aza)pyridopyrazolopyrimidinones and indazolopyrimidinones, to processes for their preparation, the compounds for use alone or in combinations in a method for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of acute and recurrent bleeding in patients with or without underlying hereditary or acquired bleeding disorders, wherein the bleeding is associated with a disease or medical intervention selected from the group consisting of menorrhagia, postpartum hemorrhage, hemorrhagic shock, trauma, surgery, transplantation, stroke, liver diseases, hereditary angioedema, nosebleed, and synovitis and cartilage damage following hemarthrosis.Type: GrantFiled: November 5, 2014Date of Patent: March 21, 2017Assignee: BAYER PHARMA AKTIENGESELLSCHAFTInventors: Jorma Haβfeld, Tom Kinzel, Johannes Köbberling, Yolanda Cancho Grande, Kristin Beyer, Susanne Röhrig, Maria Köllnberger, Michael Sperzel, Nils Burkhardt, Karl-Heinz Schlemmer, Christian Stegmann, Joachim Schuhmacher, Matthias Werner, Manuel Ellermann
-
Publication number: 20160367636Abstract: The invention relates to novel polyethylene glycol (PEG) based prodrug of Adrenomedullin, to processes for preparation thereof, to the use thereof for treatment and/or prevention of diseases, and to the use thereof for producing medicaments for treatment and/or prevention of diseases, especially of cardiovascular, edematous and/or inflammatory disorders.Type: ApplicationFiled: December 31, 2015Publication date: December 22, 2016Inventors: Ingo Flamme, Johannes Kobberling, Hans-Georg Lerchen, Nils Griebenow, Rudolf Schohe-Loop, Sven Wittrock, Maria Kollnberger, Frank Wunder, Gordon Redlich, Andreas Knorr, Julie Marley, Iain Pritchard
-
Publication number: 20160326140Abstract: The invention comprises, inter alia, pyrazolylheteroarylamides of the general formula (I) in which the A1-A4, T, W, Q, R1 and Z1-Z3 radicals are each as defined in the description. Also described are processes for preparing the compounds of the formula (I). The inventive compounds are especially suitable for controlling insects, arachnids and nematodes in agriculture and ectoparasites in veterinary medicine.Type: ApplicationFiled: December 30, 2014Publication date: November 10, 2016Applicant: Bayer Animal Health GmbHInventors: Hans-Georg SCHWARZ, Michael MAUE, Kerstin ILG, Ulrich GÖRGENS, Andreas TURBERG, Sebastian HORSTMANN, Johannes KÖBBERLING, Niels LINDNER
-
Publication number: 20160280668Abstract: The invention relates inter alia to novel compounds of the general formula (I) in which the A1-A4, T, W, Q, R1 and B1-B4 radicals are each as defined in the description. Also described are processes for preparing the compounds of the formula (I). The inventive compounds are especially suitable for controlling insects, arachnids and nematodes in agriculture, and ectoparasites in veterinary medicine.Type: ApplicationFiled: November 5, 2014Publication date: September 29, 2016Inventors: Werner HALLENBACH, Ulrich GOERGENS, Andreas TURBERG, Kerstin ILG, Sebastian HORSTMANN, Johannes KOBBERLING
-
Patent number: 9315543Abstract: The invention relates to novel tyrosine based linkers that allow the releasable connection of peptides or proteins with other molecular entities, e.g. polyethylene glycol, to processes for their preparation and their use for preparing medicaments for the treatment and/or prophylaxis of diseases.Type: GrantFiled: October 29, 2012Date of Patent: April 19, 2016Assignees: Bayer Intellectual Property GmbH, Bayer Pharma AktiengesellschaftInventors: Ingo Flamme, Johannes Köbberling, Hans-Georg Lerchen, Nils Griebenow, Rudolf Schohe-Loop, Sven Wittrock, Ursula Krenz
-
Publication number: 20160007604Abstract: The invention relates inter alia to halogen-substituted compounds of the general formula (II) in which the radicals A1-A4, T, n, W, Q, R1 and Z1-Z3 have the meanings given in the description. Also described are processes for preparing the compounds of the formula (II). The compounds according to the invention are particularly suitable for controlling insects, arachnids and nematodes in agriculture and ectoparasites in veterinary medicine.Type: ApplicationFiled: February 27, 2014Publication date: January 14, 2016Applicant: BAYER ANIMAL HEALTH GMBHInventors: Michael MAUE, Anne DECOR, Thomas BRETSCHNEIDER, Julia Johanna HAHN, Werner HALLENBACH, Reiner FISCHER, Hans-Georg SCHWARZ, Ulrich GÖRGENS, Kerstin ILG, Klaus RAMING, Johannes KÖBBERLING, Walter HÜBSCH, Andreas TURBERG